搜索筛选:
搜索耗时4.3532秒,为你在为你在102,285,761篇论文里面共找到 2 篇相符的论文内容
发布年度:
Survival spectrum of patients with primary refractory DLBCL: standard salvage chemotherapy might not
[会议论文] 作者：Feili Chen,Wenyu Li,Xiaojuan Wei,Ling Huang,Xingmiao Jiang,Hanguo Guo,Zhanli Liang,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Addition of theanti-CD20 monoclonal antibody Rituximab to chemotherapies has improved the outcome of DLBCL with over 50% of patients achieving lo...
Survival spectrum of patients with primary refractory DLBCL: standard salvage chemotherapy might not
[会议论文] 作者：Feili Chen,Wenyu Li,Xiaojuan Wei,Ling Huang,Xingmiao Jiang,Hanguo Guo,Zhanli Liang,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Addition of theanti-CD20 monoclonal antibody Rituximab to chemotherapies has improved the outcome of DLBCL with over 50% of patients achieving long-term survival....
相关搜索：
